packageNalfurafine

nalfurafine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Nalfurafine is an investigational drug that has been studied for the treatment of pruritus (itching) in patients with chronic kidney disease. It is not authorised in the European Union and remains investigational according to DrugBank.

Summary written by glm-5.3-flash from Wikidata Q6960874 and the WHO ATC classification; not checked by a person.

name:nalfurafine
ATC codes:V03AX02
DrugBank:DB13471
PubChem CID:6445230
ChEBI:136019
Wikidata:Q6960874
formula:C28H32N2O5
molar mass:476.573 g/mol (PubChem CID 6445230)
logP:1 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown